{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "23",
                "@timestamp": "2021-04-23T13:50:01.000001-04:00",
                "@year": "2021",
                "@month": "04"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2021-05-14T09:39:32.169402Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Social and Administrative Pharmacy"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "108180929"
                            },
                            "@affiliation-instance-id": "2005631485-9e11e1f60e5e57e9ede150ade52a928a",
                            "ce:source-text": "Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand;",
                            "@dptid": "108180929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Doungporn",
                                "preferred-name": {
                                    "ce:given-name": "Doungporn",
                                    "ce:initials": "D.",
                                    "ce:surname": "Leelavanich",
                                    "ce:indexed-name": "Leelavanich D."
                                },
                                "@author-instance-id": "2005631485-643e51181686a932549ced4e5b71ffb5",
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Leelavanich",
                                "@auid": "57220929529",
                                "ce:indexed-name": "Leelavanich D."
                            },
                            {
                                "ce:given-name": "Puree",
                                "preferred-name": {
                                    "ce:given-name": "Puree",
                                    "ce:initials": "P.",
                                    "ce:surname": "Anantachoti",
                                    "ce:indexed-name": "Anantachoti P."
                                },
                                "@author-instance-id": "2005631485-e88bdaef03fccf1fe100dc05870f5223",
                                "@seq": "4",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Anantachoti",
                                "@auid": "6506845858",
                                "ce:indexed-name": "Anantachoti P."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "100458316",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": {"$": "Thailand Self Medication Industry Association"},
                            "affiliation-id": {"@afid": "100458316"},
                            "@affiliation-instance-id": "2005631485-72a68924209b1231c51e17422757166e",
                            "ce:source-text": "Thailand Self Medication Industry Association, Bangkok, Thailand;"
                        },
                        "author": [{
                            "ce:given-name": "Noppadon",
                            "preferred-name": {
                                "ce:given-name": "Noppadon",
                                "ce:initials": "N.",
                                "ce:surname": "Adjimatera",
                                "ce:indexed-name": "Adjimatera N."
                            },
                            "@author-instance-id": "2005631485-5bf67a4870a284a72b525633a3589691",
                            "@seq": "2",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Adjimatera",
                            "@auid": "9250334900",
                            "ce:indexed-name": "Adjimatera N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "125551936",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": {"$": "Reckitt Benckiser (Thailand) Ltd"},
                            "affiliation-id": {"@afid": "125551936"},
                            "@affiliation-instance-id": "2005631485-7afaa8a2f3dc3163d8656a753573e72d",
                            "ce:source-text": "Reckitt Benckiser (Thailand) Ltd, Bangkok, Thailand;"
                        },
                        "author": [{
                            "ce:given-name": "Noppadon",
                            "preferred-name": {
                                "ce:given-name": "Noppadon",
                                "ce:initials": "N.",
                                "ce:surname": "Adjimatera",
                                "ce:indexed-name": "Adjimatera N."
                            },
                            "@author-instance-id": "2005631485-5bf67a4870a284a72b525633a3589691",
                            "@seq": "2",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Adjimatera",
                            "@auid": "9250334900",
                            "ce:indexed-name": "Adjimatera N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "125552434",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": {"$": "DKSH (Thailand) Limited"},
                            "affiliation-id": {"@afid": "125552434"},
                            "@affiliation-instance-id": "2005631485-be230ebaeef6684e75b0519e49ccef4c",
                            "ce:source-text": "DKSH (Thailand) Limited, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Lawanworn",
                            "preferred-name": {
                                "ce:given-name": "Lawanworn",
                                "ce:initials": "L.",
                                "ce:surname": "Broese Van Groenou",
                                "ce:indexed-name": "Broese Van Groenou L."
                            },
                            "@author-instance-id": "2005631485-82eb39bbacca4fdff775a0c71bfb2a99",
                            "@seq": "3",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Broese Van Groenou",
                            "@auid": "57220925799",
                            "ce:indexed-name": "Broese Van Groenou L."
                        }]
                    }
                ],
                "citation-title": "Prescription and non-prescription drug classification systems across countries: Lessons learned for thailand",
                "abstracts": "Â© 2020 Leelavanich et al.Purpose: The drug classification system, as prescription or non-prescription drug category, has been utilized as a regulatory strategy to ensure patient safety. In Thailand, the same system has been used for decades, though the drug classification criteria were updated to accommodate drug re-classification in 2016. These new criteria, however, have not been applied retroactively. Inconsistency in drug classification has been observed leading to concerns regarding the drug classification system. This has prompted the need for a review of the drug classification system in Thailand. This study aims to explore Thailand and other selected countries\u2019 regulatory management regarding the drug classification system, drug classification criteria, and drug classification itself. Methods: The drug classification systems of the United States, the United Kingdom, Japan, Singapore, Malaysia, the Philippines, and Canada were selected to study alongside Thailand\u2019s system. The regulatory review was conducted through each country\u2019s drug regulatory agency website and available published research. Complementary interviews with drug regulatory authorities were conducted when written documentation was unclear and had limited access. Fifty-two common drugs were selected to compare their actual classifications across the different countries. Results: All selected countries classified drugs into two major groups: prescription drugs and non-prescription drugs. The studied countries further sub-classified non-prescription drugs into 1\u20134 categories. Principles of drug classification criteria among countries are similar; they comprised of three themes: disease characteristics, drug safety profile, and other drug char-acteristics. Actual drug classification of antibiotics, dyslipidemia treatments, and hypertension treatments in Thailand are notedly different from other countries. Furthermore, 77.4% of drugs studied in Thailand fall into the behind-the-counter (dangerous) drug category, which varied from antihistamines to antibiotics, dyslipidemia treatments, and vaccines. Conclusion: Thailand\u2019s drug classification criteria are comparable with other nations; however, there is a need to review drug classification statuses as many drugs have been classified into improper drug categories.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Social and Administrative Pharmacy"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "* Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Puree",
                        "ce:initials": "P.",
                        "ce:surname": "Anantachoti",
                        "ce:indexed-name": "Anantachoti P."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Classification criteria",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Drug category",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Drug regulatory",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Non-prescription",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "OTC",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Prescription",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Risk Manage. Healthc. Policy",
                    "website": {"ce:e-address": {
                        "$": "https://www.dovepress.com/getfile.php?fileID=64156",
                        "@type": "email"
                    }},
                    "@country": "nzl",
                    "translated-sourcetitle": {
                        "$": "Risk Management and Healthcare Policy",
                        "@xml:lang": "eng"
                    },
                    "issn": {
                        "$": "11791594",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {"@volume": "13"},
                        "pagerange": {
                            "@first": "2753",
                            "@last": "2768"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Dove Medical Press Ltd"},
                    "sourcetitle": "Risk Management and Healthcare Policy",
                    "@srcid": "19700182697",
                    "publicationdate": {
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2020"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "EMCLASS",
                        "classification": [
                            {
                                "classification-code": "17",
                                "classification-description": "Public Health, Social Medicine and Epidemiology"
                            },
                            {
                                "classification-code": "37",
                                "classification-description": "Drug Literature Index"
                            }
                        ]
                    },
                    {
                        "@type": "ASJC",
                        "classification": [
                            {"$": "2719"},
                            {"$": "2739"}
                        ]
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "03",
                    "@timestamp": "BST 12:04:23",
                    "@year": "2021",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005631485",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "930326392",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20201132077",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2020531805",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20203151918",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2020507877",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20204445329",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200010405374",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85097869212",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85097869212",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.2147/RMHP.S281629"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "89",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sukrod N. Principle of Thailand medicine reclassification guidelines; 2015. Available from: http://www.tsmia.or.th/RTD2015/5-THAILAND%20(Sept%2017)%20Drug%20reclassification% 20guideline%20(final).pdf. Accessed April 23, 2020.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.tsmia.or.th/RTD2015/5-THAILAND%20(Sept%2017)%20Drug%20reclassification%20guideline%20(final).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097873422",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 23, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "ce:surname": "Sukrod",
                                "ce:indexed-name": "Sukrod N."
                            }]},
                            "ref-sourcetitle": "Principle of Thailand medicine reclassification guidelines"
                        },
                        "ce:source-text": "Sukrod N. Principle of Thailand medicine reclassification guidelines; 2015. Available from: http://www.tsmia.or.th/RTD2015/5-THAILAND%20(Sept%2017)%20Drug%20reclassification% 20guideline%20(final).pdf. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Consumer Healthcare Product Association. Rx-to-OTC switch; 2019. Available from: https://www.chpa.org/switch.aspx. Accessed October 23, 2019.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.chpa.org/switch.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097875119",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Consumer Healthcare Product Association. Accessed October 23, 2019",
                            "ref-sourcetitle": "Rx-to-OTC switch"
                        },
                        "ce:source-text": "Consumer Healthcare Product Association. Rx-to-OTC switch; 2019. Available from: https://www.chpa.org/switch.aspx. Accessed October 23, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "GOV.UK. Oral diclofenac presentations with legal status \u2018P\u2019 \u2013 reclassified to POM; 2015. Available from: https://www.gov.uk/drug-device-alerts/drug-alert-oral-diclofenac-presentations-with-legal-status-p-reclassified-to-pom. Accessed Oct 23, 2019.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.gov.uk/drug-device-alerts/drug-alert-oral-diclofenac-presentations-with-legal-status-p-reclassified-to-pom",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84940117328",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "GOV.UK. Accessed Oct 23, 2019",
                            "ref-sourcetitle": "Oral diclofenac presentations with legal status \u2018P\u2019 \u2013 reclassified to POM"
                        },
                        "ce:source-text": "GOV.UK. Oral diclofenac presentations with legal status \u2018P\u2019 \u2013 reclassified to POM; 2015. Available from: https://www.gov.uk/drug-device-alerts/drug-alert-oral-diclofenac-presentations-with-legal-status-p-reclassified-to-pom. Accessed Oct 23, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Consumer Healthcare Product Association. Rx-to-OTC switch: switch list; 2018. Available from: https://www.chpa.org/Switch.aspx. Accessed October 26, 2019.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.chpa.org/Switch.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097899007",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Consumer Healthcare Product Association. Accessed October 26, 2019",
                            "ref-sourcetitle": "Rx-to-OTC switch: switch list"
                        },
                        "ce:source-text": "Consumer Healthcare Product Association. Rx-to-OTC switch: switch list; 2018. Available from: https://www.chpa.org/Switch.aspx. Accessed October 26, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Bank Group President Jim Yong Kim. Speech by World bank group president Jim Yong Kim on universal health coverage in emerging economies; 2014. Available from: https://www.worldbank.org/en/news/speech/2014/01/14/speech-world-bank-group-president-jim-yong-kim-health-emerging-economies. Accessed August 2, 2020.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.worldbank.org/en/news/speech/2014/01/14/speech-world-bank-group-president-jim-yong-kim-health-emerging-economies",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044154290",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Bank Group President Jim Yong Kim. Accessed August 2, 2020",
                            "ref-sourcetitle": "Speech by World bank group president Jim Yong Kim on universal health coverage in emerging economies"
                        },
                        "ce:source-text": "World Bank Group President Jim Yong Kim. Speech by World bank group president Jim Yong Kim on universal health coverage in emerging economies; 2014. Available from: https://www.worldbank.org/en/news/speech/2014/01/14/speech-world-bank-group-president-jim-yong-kim-health-emerging-economies. Accessed August 2, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sakulbumrunsul R, Taychakhoonavudh S. Pricing and patient access framework to support universal coverage in Thailand. Available from: http://www.pharm.chula.ac.th/dept5/source/images/data/files/NHSO_ PPA_Report_240317(2).pdf. Accessed December 17, 2020.",
                        "@id": "6",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.pharm.chula.ac.th/dept5/source/images/data/files/NHSO_PPA_Report_240317(2).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097879471",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed December 17, 2020",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Sakulbumrunsul",
                                    "ce:indexed-name": "Sakulbumrunsul R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Taychakhoonavudh",
                                    "ce:indexed-name": "Taychakhoonavudh S."
                                }
                            ]},
                            "ref-sourcetitle": "Pricing and patient access framework to support universal coverage in Thailand"
                        },
                        "ce:source-text": "Sakulbumrunsul R, Taychakhoonavudh S. Pricing and patient access framework to support universal coverage in Thailand. Available from: http://www.pharm.chula.ac.th/dept5/source/images/data/files/NHSO_ PPA_Report_240317(2).pdf. Accessed December 17, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Strategy and planning division: Office of the Permanent Secretary for Ministry of Public Health. Number of hospitals by category in Thailand; 2014. Available from: http://203.157.10.8/hcode_2014/query_02.php?p=3%20/. Accessed April 12, 2020.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://203.157.10.8/hcode_2014/query_02.php?p=3%20/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097878633",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "of hospitals by category in Thailand; Accessed April 12, 2020",
                            "ref-sourcetitle": "Strategy and planning division: Office of the Permanent Secretary for Ministry of Public Health"
                        },
                        "ce:source-text": "Strategy and planning division: Office of the Permanent Secretary for Ministry of Public Health. Number of hospitals by category in Thailand; 2014. Available from: http://203.157.10.8/hcode_2014/query_02.php?p=3%20/. Accessed April 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Number of pharmacies; 2017. Available from: http://www.fda.moph.go.th/sites/drug/Shared% 20Documents/Statistic/establishment.pdf. Accessed April 23, 2020.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Statistic/establishment.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097873973",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed April 23, 2020",
                            "ref-sourcetitle": "Number of pharmacies"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Number of pharmacies; 2017. Available from: http://www.fda.moph.go.th/sites/drug/Shared% 20Documents/Statistic/establishment.pdf. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Saramunee K, Chaiyasong S, Krska J. Public health roles for community pharmacy: contrasts and similarities between England and Thailand. Isan J Pharm Sci. 2011;7(2):1\u201311.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Public health roles for community pharmacy: contrasts and similarities between England and Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892743659",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "11"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Saramunee",
                                    "ce:indexed-name": "Saramunee K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Chaiyasong",
                                    "ce:indexed-name": "Chaiyasong S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Krska",
                                    "ce:indexed-name": "Krska J."
                                }
                            ]},
                            "ref-sourcetitle": "Isan J Pharm Sci"
                        },
                        "ce:source-text": "Saramunee K, Chaiyasong S, Krska J. Public health roles for community pharmacy: contrasts and similarities between England and Thailand. Isan J Pharm Sci. 2011;7(2):1\u201311."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Designation of number of type 2 community pharmacies; 2005. Available from: http://www.ratcha kitcha.soc.go.th/DATA/PDF/2548/00155157.PDF?fbclid= IwAR2Qksp4wyeb5ZnkhGZXUNyigAjknzu92GMReDzdSdIfZGWj d6E32VwRwwE. Accessed April 23, 2020.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.ratchakitcha.soc.go.th/DATA/PDF/2548/00155157.PDF?fbclid=IwAR2Qksp4wyeb5ZnkhGZXUNyigAjknzu92GMReDzdSdIfZGWjd6E32VwRwwE",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097885030",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed April 23, 2020",
                            "ref-sourcetitle": "Designation of number of type 2 community pharmacies"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Designation of number of type 2 community pharmacies; 2005. Available from: http://www.ratcha kitcha.soc.go.th/DATA/PDF/2548/00155157.PDF?fbclid= IwAR2Qksp4wyeb5ZnkhGZXUNyigAjknzu92GMReDzdSdIfZGWj d6E32VwRwwE. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Guideline of drug reclassification; 2016. Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/reclass/%E0%B8%A0%E0%B8% B2%E0%B8%84%E0%B8%9C%E0%B8%99%E0%B8%A7%E0% B8%81%20%E0%B8%84.pdf. Accessed Oct 23, 2019.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.moph.go.th/sites/drug/Shared%20Documents/reclass/%E0%B8%A0%E0%B8%B2%E0%B8%84%E0%B8%9C%E0%B8%99%E0%B8%A7%E0%B8%81%20%E0%B8%84.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097867706",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed Oct 23, 2019",
                            "ref-sourcetitle": "Guideline of drug reclassification"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Guideline of drug reclassification; 2016. Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/reclass/%E0%B8%A0%E0%B8% B2%E0%B8%84%E0%B8%9C%E0%B8%99%E0%B8%A7%E0% B8%81%20%E0%B8%84.pdf. Accessed Oct 23, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The drug act (No. 6) B.E. 2562 (A.D. 2019). Available from: https://sme.go.th/upload/mod_download/download-20190508065825.PDF. Accessed December 18, 2019.",
                        "@id": "12",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://sme.go.th/upload/mod_download/download-20190508065825.PDF",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097887753",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed December 18, 2019",
                            "ref-sourcetitle": "The drug act (No. 6) B.E. 2562 (A.D. 2019)"
                        },
                        "ce:source-text": "The drug act (No. 6) B.E. 2562 (A.D. 2019). Available from: https://sme.go.th/upload/mod_download/download-20190508065825.PDF. Accessed December 18, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. Thailand pharmaceutical profile; 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/274873/2017-Thailand-pharm-profile.pdf?sequence=1&isAllowed=y. Accessed April 23, 2020.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://apps.who.int/iris/bitstream/handle/10665/274873/2017-Thailand-pharm-profile.pdf?sequence=1&isAllowed=y",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097904015",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed April 23, 2020",
                            "ref-sourcetitle": "Thailand pharmaceutical profile"
                        },
                        "ce:source-text": "World Health Organization. Thailand pharmaceutical profile; 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/274873/2017-Thailand-pharm-profile.pdf?sequence=1&isAllowed=y. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chan RC, Ching PL. Pharmacy practice in Thailand. Am J Health Syst Pharm. 2005;62(13):1408\u20131411. doi:10.2146/ajhp040393",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Pharmacy practice in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2146/ajhp040393",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "22144443488",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "62",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1408",
                                    "@last": "1411"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RC",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan RC"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "PL.",
                                    "@_fa": "true",
                                    "ce:surname": "Ching",
                                    "ce:indexed-name": "Ching PL."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Health Syst Pharm"
                        },
                        "ce:source-text": "Chan RC, Ching PL. Pharmacy practice in Thailand. Am J Health Syst Pharm. 2005;62(13):1408\u20131411. doi:10.2146/ajhp040393"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sriviriyanupap W. Developing indicators and method of drug classification according to Thai law. Thai J Pharm Sci. 2016;40.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Developing indicators and method of drug classification according to Thai law"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84975489470",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {"@volume": "40"}},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "ce:surname": "Sriviriyanupap",
                                "ce:indexed-name": "Sriviriyanupap W."
                            }]},
                            "ref-sourcetitle": "Thai J Pharm Sci"
                        },
                        "ce:source-text": "Sriviriyanupap W. Developing indicators and method of drug classification according to Thai law. Thai J Pharm Sci. 2016;40."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "MGR Online. The propose of new drug classification scheme; 2018. Available from: https://mgronline.com/qol/detail/9610000088655. Accessed October 25, 2019.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://mgronline.com/qol/detail/9610000088655",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097867209",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "MGR Online. Accessed October 25, 2019",
                            "ref-sourcetitle": "The propose of new drug classification scheme"
                        },
                        "ce:source-text": "MGR Online. The propose of new drug classification scheme; 2018. Available from: https://mgronline.com/qol/detail/9610000088655. Accessed October 25, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics smart use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ. 2012;90(12):905\u2013913. doi:10. 2471/BLT.12.105445",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Antibiotics smart use: a workable model for promoting the rational use of medicines in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2471/BLT.12.105445",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84870445778",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "90",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "905",
                                    "@last": "913"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Sumpradit",
                                        "ce:indexed-name": "Sumpradit N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Chongtrakul",
                                        "ce:indexed-name": "Chongtrakul P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Anuwong",
                                        "ce:indexed-name": "Anuwong K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bull World Health Organ"
                        },
                        "ce:source-text": "Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics smart use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ. 2012;90(12):905\u2013913. doi:10. 2471/BLT.12.105445"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bangkok Post. Teens taking \u2018taxi\u2019 ride to drug addiction; 2018. Available from: https://www.bangkokpost.com/thailand/special-reports/1529006/teens-taking-taxi-ride-to-drug-addiction. Accessed April 23, 2020.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.bangkokpost.com/thailand/special-reports/1529006/teens-taking-taxi-ride-to-drug-addiction",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097911780",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Bangkok Post. Accessed April 23, 2020",
                            "ref-sourcetitle": "Teens taking \u2018taxi\u2019 ride to drug addiction"
                        },
                        "ce:source-text": "Bangkok Post. Teens taking \u2018taxi\u2019 ride to drug addiction; 2018. Available from: https://www.bangkokpost.com/thailand/special-reports/1529006/teens-taking-taxi-ride-to-drug-addiction. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Counterfeit drug manufacturing was found; 2018. Available from: http://pca.fda.moph.go.th/public_media_ detail.php?id=2&cat=50&content_id=1671. Accessed April 25, 2020.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://pca.fda.moph.go.th/public_media_detail.php?id=2&cat=50&content_id=1671",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097909751",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "Counterfeit drug manufacturing was found"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Counterfeit drug manufacturing was found; 2018. Available from: http://pca.fda.moph.go.th/public_media_ detail.php?id=2&cat=50&content_id=1671. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Risks of 4x100 (pro drug); 2020. Available from: https://oryor.com/oryor_miniweb/knowledge_ detail.php?cat=2&id=7. Accessed April 23, 2020.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://oryor.com/oryor_miniweb/knowledge_detail.php?cat=2&id=7",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097891420",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed April 23, 2020",
                            "ref-sourcetitle": "Risks of 4x100 (pro drug)"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Risks of 4x100 (pro drug); 2020. Available from: https://oryor.com/oryor_miniweb/knowledge_ detail.php?cat=2&id=7. Accessed April 23, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Drug database; 2019. Available from: http://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/FRM_SEARCH_DRUG.aspx. Accessed November 4, 2019.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/FRM_SEARCH_DRUG.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85074676090",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed November 4, 2019",
                            "ref-sourcetitle": "Drug database"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Drug database; 2019. Available from: http://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/FRM_SEARCH_DRUG.aspx. Accessed November 4, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "GOV.UK. Medicines: reclassify your product; 2019. Available from: https://www.gov.uk/guidance/medicines-reclassify-your-product#classifications-of-medicines. Accessed October 23, 2019.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.gov.uk/guidance/medicines-reclassify-your-product#classifications-of-medicines",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097901586",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "GOV.UK. Accessed October 23, 2019",
                            "ref-sourcetitle": "Medicines: reclassify your product"
                        },
                        "ce:source-text": "GOV.UK. Medicines: reclassify your product; 2019. Available from: https://www.gov.uk/guidance/medicines-reclassify-your-product#classifications-of-medicines. Accessed October 23, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Homhuan A. Amendments to Thailand\u2019s drug act; 2019. Available from: https://www.tilleke.com/resources/amendments-thailand%E2% 80%99s-drug-act. Accessed August 2, 2020.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.tilleke.com/resources/amendments-thailand%E2%80%99s-drug-act",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097862079",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed August 2, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Homhuan",
                                "ce:indexed-name": "Homhuan A."
                            }]},
                            "ref-sourcetitle": "Amendments to Thailand\u2019s drug act"
                        },
                        "ce:source-text": "Homhuan A. Amendments to Thailand\u2019s drug act; 2019. Available from: https://www.tilleke.com/resources/amendments-thailand%E2% 80%99s-drug-act. Accessed August 2, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Manag Healthc Policy. 2016;9:173. doi:10.2147/RMHP.S98099",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2147/RMHP.S98099",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84982296502",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "173"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Nomura",
                                    "ce:indexed-name": "Nomura K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Kitagawa",
                                    "ce:indexed-name": "Kitagawa Y"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Yuda",
                                    "ce:indexed-name": "Yuda Y"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Takano-Ohmuro",
                                    "ce:indexed-name": "Takano-Ohmuro H."
                                }
                            ]},
                            "ref-sourcetitle": "Risk Manag Healthc Policy"
                        },
                        "ce:source-text": "Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Manag Healthc Policy. 2016;9:173. doi:10.2147/RMHP.S98099"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gauld NJ, Kelly FS, Emmerton LM, Buetow SA. Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand. PLoS One. 2015;10(3):e0119011. doi:10.1371/journal.pone.0119011",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0119011",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84925835182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "e0119011"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NJ",
                                    "@_fa": "true",
                                    "ce:surname": "Gauld",
                                    "ce:indexed-name": "Gauld NJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "FS",
                                    "@_fa": "true",
                                    "ce:surname": "Kelly",
                                    "ce:indexed-name": "Kelly FS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "LM",
                                    "@_fa": "true",
                                    "ce:surname": "Emmerton",
                                    "ce:indexed-name": "Emmerton LM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "SA.",
                                    "@_fa": "true",
                                    "ce:surname": "Buetow",
                                    "ce:indexed-name": "Buetow SA."
                                }
                            ]},
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Gauld NJ, Kelly FS, Emmerton LM, Buetow SA. Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand. PLoS One. 2015;10(3):e0119011. doi:10.1371/journal.pone.0119011"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gauld NJ, Kelly FS, Kurosawa N, Bryant LJ, Emmerton LM, Buetow SA. Widening consumer access to medicines through switch-ing medicines to non-prescription: a six country comparison. PLoS One. 2014;9(9):e107726. doi:10.1371/journal.pone.0107726",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Widening consumer access to medicines through switch-ing medicines to non-prescription: a six country comparison"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0107726",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84907452555",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "e107726"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NJ",
                                    "@_fa": "true",
                                    "ce:surname": "Gauld",
                                    "ce:indexed-name": "Gauld NJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "FS",
                                    "@_fa": "true",
                                    "ce:surname": "Kelly",
                                    "ce:indexed-name": "Kelly FS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Kurosawa",
                                    "ce:indexed-name": "Kurosawa N"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "LJ",
                                    "@_fa": "true",
                                    "ce:surname": "Bryant",
                                    "ce:indexed-name": "Bryant LJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "LM",
                                    "@_fa": "true",
                                    "ce:surname": "Emmerton",
                                    "ce:indexed-name": "Emmerton LM"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "SA.",
                                    "@_fa": "true",
                                    "ce:surname": "Buetow",
                                    "ce:indexed-name": "Buetow SA."
                                }
                            ]},
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Gauld NJ, Kelly FS, Kurosawa N, Bryant LJ, Emmerton LM, Buetow SA. Widening consumer access to medicines through switch-ing medicines to non-prescription: a six country comparison. PLoS One. 2014;9(9):e107726. doi:10.1371/journal.pone.0107726"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. Proposal for updating the definition of stringent regulatory authority; 2017. Available from: https://www. who.int/medicines/areas/quality_safety/quality_assurance/SRA_ QAS17-728Rev1_31082017.pdf?ua=1. Accessed October 26, 2019.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/medicines/areas/quality_safety/quality_assurance/SRA_QAS17-728Rev1_31082017.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85066321750",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed October 26, 2019",
                            "ref-sourcetitle": "Proposal for updating the definition of stringent regulatory authority"
                        },
                        "ce:source-text": "World Health Organization. Proposal for updating the definition of stringent regulatory authority; 2017. Available from: https://www. who.int/medicines/areas/quality_safety/quality_assurance/SRA_ QAS17-728Rev1_31082017.pdf?ua=1. Accessed October 26, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Members & observers; 2019. Available from: https://www.ich.org/page/members-observers. Accessed October 26, 2019.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ich.org/page/members-observers",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85074537771",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Accessed October 26, 2019",
                            "ref-sourcetitle": "Members & observers"
                        },
                        "ce:source-text": "The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Members & observers; 2019. Available from: https://www.ich.org/page/members-observers. Accessed October 26, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Association of Southeast Asian Nations. ASEAN member states; 2019. Available from: https://asean.org/asean/asean-member-states/. Accessed December 10, 2019.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://asean.org/asean/asean-member-states/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097871639",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Association of Southeast Asian Nations. Accessed December 10, 2019",
                            "ref-sourcetitle": "ASEAN member states"
                        },
                        "ce:source-text": "Association of Southeast Asian Nations. ASEAN member states; 2019. Available from: https://asean.org/asean/asean-member-states/. Accessed December 10, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Filmer D, Rogers H, Angrist N, Sabarwal S. Learning-Adjusted Years of Schooling (LAYS): Defining a New Macro Measure of Education. The World Bank; 2018.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85080579521",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The World Bank",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Filmer",
                                    "ce:indexed-name": "Filmer D"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Rogers",
                                    "ce:indexed-name": "Rogers H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Angrist",
                                    "ce:indexed-name": "Angrist N"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Sabarwal",
                                    "ce:indexed-name": "Sabarwal S."
                                }
                            ]},
                            "ref-sourcetitle": "Learning-Adjusted Years of Schooling (LAYS): Defining a New Macro Measure of Education"
                        },
                        "ce:source-text": "Filmer D, Rogers H, Angrist N, Sabarwal S. Learning-Adjusted Years of Schooling (LAYS): Defining a New Macro Measure of Education. The World Bank; 2018."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Human development index (HDI) by country; 2019. Available from: http://worldpopulationreview.com/countries/hdi-by-country/. Accessed January 12, 2020.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://worldpopulationreview.com/countries/hdi-by-country/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85081958235",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed January 12, 2020",
                            "ref-sourcetitle": "Human development index (HDI) by country"
                        },
                        "ce:source-text": "Human development index (HDI) by country; 2019. Available from: http://worldpopulationreview.com/countries/hdi-by-country/. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "United Nations Development Programme. Global human development indicators; 2020. Available from: http://hdr.undp.org/en/coun tries/profiles/. Accessed April 25, 2020.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://hdr.undp.org/en/countries/profiles/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84995702439",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "United Nations Development Programme. Accessed April 25, 2020",
                            "ref-sourcetitle": "Global human development indicators"
                        },
                        "ce:source-text": "United Nations Development Programme. Global human development indicators; 2020. Available from: http://hdr.undp.org/en/coun tries/profiles/. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The World Bank. Education Statistics. 2019. Available from: https://databank.worldbank.org/indicator/UIS.SAP.CE?id=c755d342&re port_name=EdStats_Indicators_Report&populartype=series. Accessed January 12, 2020.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://databank.worldbank.org/indicator/UIS.SAP.CE?id=c755d342&report_name=EdStats_Indicators_Report&populartype=series",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "0004212508",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The World Bank. Accessed January 12, 2020",
                            "ref-sourcetitle": "Education Statistics"
                        },
                        "ce:source-text": "The World Bank. Education Statistics. 2019. Available from: https://databank.worldbank.org/indicator/UIS.SAP.CE?id=c755d342&re port_name=EdStats_Indicators_Report&populartype=series. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. Density of physicians. Available from: https://www.who.int/gho/health_workforce/physicians_density/en/. Accessed April 25, 2020.",
                        "@id": "34",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/gho/health_workforce/physicians_density/en/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85041411302",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed April 25, 2020",
                            "ref-sourcetitle": "Density of physicians"
                        },
                        "ce:source-text": "World Health Organization. Density of physicians. Available from: https://www.who.int/gho/health_workforce/physicians_density/en/. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "World Health Organization. Pharmacists (per 10,000 populations). Available from: https://www.who.int/data/gho/data/indicators/indica tor-details/GHO/pharmacists-(per-10-000-population). Accessed April 25, 2020.",
                        "@id": "35",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/data/gho/data/indicators/indicator-details/GHO/pharmacists-(per-10-000-population",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097862388",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization). Accessed April 25, 2020",
                            "ref-sourcetitle": "Pharmacists (per 10,000 populations)"
                        },
                        "ce:source-text": "World Health Organization. Pharmacists (per 10,000 populations). Available from: https://www.who.int/data/gho/data/indicators/indica tor-details/GHO/pharmacists-(per-10-000-population). Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Collins S. A tale of two countries: the path to pharmacist prescribing in the United Kingdom and Canada; 2014. Available from: https://www.pharmacist.com/article/tale-two-countries-path-pharmacist-prescribing-united-kingdom-and-canada. Accessed Jan 12, 2020.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pharmacist.com/article/tale-two-countries-path-pharmacist-prescribing-united-kingdom-and-canada",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84973107498",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Collins",
                                "ce:indexed-name": "Collins S."
                            }]},
                            "ref-sourcetitle": "A tale of two countries: the path to pharmacist prescribing in the United Kingdom and Canada"
                        },
                        "ce:source-text": "Collins S. A tale of two countries: the path to pharmacist prescribing in the United Kingdom and Canada; 2014. Available from: https://www.pharmacist.com/article/tale-two-countries-path-pharmacist-prescribing-united-kingdom-and-canada. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Deloitte Access Economics. Remuneration and regulation of community pharmacy; 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/4E0B6EEE19F56A40CA2 581470016D688/$File/deloitte-community-pharmacy-literature-review-2016.pdf. Accessed January 12, 2020.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www1.health.gov.au/internet/main/publishing.nsf/Content/4E0B6EEE19F56A40CA2581470016D688/$File/deloitte-community-pharmacy-literature-review-2016.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85073080598",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Deloitte Access Economics. Accessed January 12, 2020",
                            "ref-sourcetitle": "Remuneration and regulation of community pharmacy"
                        },
                        "ce:source-text": "Deloitte Access Economics. Remuneration and regulation of community pharmacy; 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/4E0B6EEE19F56A40CA2 581470016D688/$File/deloitte-community-pharmacy-literature-review-2016.pdf. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nakagawa S, Kume N. Pharmacy practice in Japan. Can J Hosp Pharm. 2017;70(3):232. doi:10.4212/cjhp.v70i3.1663",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Pharmacy practice in Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4212/cjhp.v70i3.1663",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85022020286",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "70",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "232"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Nakagawa",
                                    "ce:indexed-name": "Nakagawa S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Kume",
                                    "ce:indexed-name": "Kume N."
                                }
                            ]},
                            "ref-sourcetitle": "Can J Hosp Pharm"
                        },
                        "ce:source-text": "Nakagawa S, Kume N. Pharmacy practice in Japan. Can J Hosp Pharm. 2017;70(3):232. doi:10.4212/cjhp.v70i3.1663"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Competency standards for Singapore pharmacists; 2010. Available from: https://www.healthprofessionals.gov.sg/docs/librariesprovider3/forms-publications/competency-standards-for-singapore-pharmacists-(march-2010).pdf. Accessed November 13, 2020.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.healthprofessionals.gov.sg/docs/librariesprovider3/forms-publications/competency-standards-for-singapore-pharmacists-(march-2010).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865187330",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed November 13, 2020",
                            "ref-sourcetitle": "Competency standards for Singapore pharmacists"
                        },
                        "ce:source-text": "Competency standards for Singapore pharmacists; 2010. Available from: https://www.healthprofessionals.gov.sg/docs/librariesprovider3/forms-publications/competency-standards-for-singapore-pharmacists-(march-2010).pdf. Accessed November 13, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chau A. Are pharmacists\u2019 roles as primary health professionals underutilised in Singapore? 2016. Available from: https://today. mims.com/are-pharmacists\u2019roles-as-primary-health-professionals-underutilised-in-singapore-?channel=GN-Local-News-SG. Accessed Jan 12, 2020.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://today.mims.com/are-pharmacists\u2019roles-as-primary-health-professionals-underutilised-in-singapore-?channel=GN-Local-News-SG",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097891002",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Chau",
                                "ce:indexed-name": "Chau A."
                            }]},
                            "ref-sourcetitle": "Are pharmacists\u2019 roles as primary health professionals underutilised in Singapore?"
                        },
                        "ce:source-text": "Chau A. Are pharmacists\u2019 roles as primary health professionals underutilised in Singapore? 2016. Available from: https://today. mims.com/are-pharmacists\u2019roles-as-primary-health-professionals-underutilised-in-singapore-?channel=GN-Local-News-SG. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "General Pharmaceutical Council. What does a pharmacist do? 2019. Available from: https://www.pharmacyregulation.org/raising-concerns/raising-concerns-about-pharmacy-professional/what-expect-your-pharmacy/what-does-0. Accessed January 12, 2020.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pharmacyregulation.org/raising-concerns/raising-concerns-about-pharmacy-professional/what-expect-your-pharmacy/what-does-0",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097908598",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "General Pharmaceutical Council. Accessed January 12, 2020",
                            "ref-sourcetitle": "What does a pharmacist do?"
                        },
                        "ce:source-text": "General Pharmaceutical Council. What does a pharmacist do? 2019. Available from: https://www.pharmacyregulation.org/raising-concerns/raising-concerns-about-pharmacy-professional/what-expect-your-pharmacy/what-does-0. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Albanese NP, Rouse MJ, Schlaifer M. Pharmacy CoCi. Scope of contemporary pharmacy practice: roles, responsibilities, and func-tions of pharmacists and pharmacy technicians. J Am Pharm Assoc. 2010;50(2):e35\u2013e69. doi:10.1331/JAPhA.2010.10510",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Pharmacy CoCi. Scope of contemporary pharmacy practice: roles, responsibilities, and func-tions of pharmacists and pharmacy technicians"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1331/JAPhA.2010.10510",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84858235630",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "e35",
                                    "@last": "e69"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NP",
                                    "@_fa": "true",
                                    "ce:surname": "Albanese",
                                    "ce:indexed-name": "Albanese NP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "MJ",
                                    "@_fa": "true",
                                    "ce:surname": "Rouse",
                                    "ce:indexed-name": "Rouse MJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Schlaifer",
                                    "ce:indexed-name": "Schlaifer M."
                                }
                            ]},
                            "ref-sourcetitle": "J Am Pharm Assoc"
                        },
                        "ce:source-text": "Albanese NP, Rouse MJ, Schlaifer M. Pharmacy CoCi. Scope of contemporary pharmacy practice: roles, responsibilities, and func-tions of pharmacists and pharmacy technicians. J Am Pharm Assoc. 2010;50(2):e35\u2013e69. doi:10.1331/JAPhA.2010.10510"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Poisons act 1952 and regulations; 2019. Available from: http://www. agc.gov.my/agcportal/uploads/files/Publications/LOM/EN/Act% 20366%20online.pdf. Accessed January 12, 2020.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.agc.gov.my/agcportal/uploads/files/Publications/LOM/EN/Act%20366%20online.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097894551",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed January 12, 2020",
                            "ref-sourcetitle": "Poisons act 1952 and regulations"
                        },
                        "ce:source-text": "Poisons act 1952 and regulations; 2019. Available from: http://www. agc.gov.my/agcportal/uploads/files/Publications/LOM/EN/Act% 20366%20online.pdf. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Annuar A. Counter-productive\u2019 for pharmacists to administer vac-cines, doctors\u2019 body says; 2019. Available from: https://www.malay mail.com/news/malaysia/2019/02/25/counter-productive-for-pharmacists-to-administer-vaccines-doctors-body-says/1726723. Accessed January 12, 2020.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.malaymail.com/news/malaysia/2019/02/25/counter-productive-for-pharmacists-to-administer-vaccines-doctors-body-says/1726723",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097866722",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed January 12, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Annuar",
                                "ce:indexed-name": "Annuar A."
                            }]},
                            "ref-sourcetitle": "Counter-productive\u2019 for pharmacists to administer vac-cines, doctors\u2019 body says"
                        },
                        "ce:source-text": "Annuar A. Counter-productive\u2019 for pharmacists to administer vac-cines, doctors\u2019 body says; 2019. Available from: https://www.malay mail.com/news/malaysia/2019/02/25/counter-productive-for-pharmacists-to-administer-vaccines-doctors-body-says/1726723. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Philippine Pharmacy Act. 2015. Available from: https://www.lawphil. net/statutes/repacts/ra2016/ra_10918_2016.html. Accessed Jan 12, 2020.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.lawphil.net/statutes/repacts/ra2016/ra_10918_2016.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097899192",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Philippine Pharmacy Act. Accessed Jan 12, 2020"
                        },
                        "ce:source-text": "Philippine Pharmacy Act. 2015. Available from: https://www.lawphil. net/statutes/repacts/ra2016/ra_10918_2016.html. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "International Pharmaceutical Federation. An overview of current pharmacy impact on immunisation; 2016. Available from: https://www.fip.org/www/streamfile.php?filename=fip/publications/FIP_ report_on_Immunisation.pdf. Accessed Jan 12, 2020.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fip.org/www/streamfile.php?filename=fip/publications/FIP_report_on_Immunisation.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048243605",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "International Pharmaceutical Federation. Accessed Jan 12, 2020",
                            "ref-sourcetitle": "An overview of current pharmacy impact on immunisation"
                        },
                        "ce:source-text": "International Pharmaceutical Federation. An overview of current pharmacy impact on immunisation; 2016. Available from: https://www.fip.org/www/streamfile.php?filename=fip/publications/FIP_ report_on_Immunisation.pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pharmaceutical Profession Act (No.2). 2015. Available from: https://library2.parliament.go.th/giventake/content_nla2557/law21-260358-69.pdf. Accessed Jan 12, 2020.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://library2.parliament.go.th/giventake/content_nla2557/law21-260358-69.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097877385",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-sourcetitle": "Pharmaceutical Profession Act (No.2)"
                        },
                        "ce:source-text": "Pharmaceutical Profession Act (No.2). 2015. Available from: https://library2.parliament.go.th/giventake/content_nla2557/law21-260358-69.pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "U.S. Food and Drug Administration. Prescription drug advertising; 2019. Available from: https://www.fda.gov/drugs/drug-information-consumers/prescription-drug-advertising. Accessed April 25, 2020.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/drugs/drug-information-consumers/prescription-drug-advertising",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076417135",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "Prescription drug advertising"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. Prescription drug advertising; 2019. Available from: https://www.fda.gov/drugs/drug-information-consumers/prescription-drug-advertising. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "GOV.UK. Advertise your medicines; 2020. Available from: https://www.gov.uk/guidance/advertise-your-medicines#advertise-to-the-public. Accessed April 25, 2020.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.gov.uk/guidance/advertise-your-medicines#advertise-to-the-public",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097910069",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "GOV.UK. Accessed April 25, 2020",
                            "ref-sourcetitle": "Advertise your medicines"
                        },
                        "ce:source-text": "GOV.UK. Advertise your medicines; 2020. Available from: https://www.gov.uk/guidance/advertise-your-medicines#advertise-to-the-public. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Graham JS, Swanson R. Distribution and marketing of drugs in Canada: overview; 2018. Available from: https://ca.practicallaw.thom sonreuters.com/0-618-6695?transitionType=Default&contextData= (sc.Default)&firstPage=true&bhcp=1. Accessed April 25, 2020.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ca.practicallaw.thomsonreuters.com/0-618-6695?transitionType=Default&contextData=(sc.Default)&firstPage=true&bhcp=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097909376",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 25, 2020",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JS",
                                    "@_fa": "true",
                                    "ce:surname": "Graham",
                                    "ce:indexed-name": "Graham JS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Swanson",
                                    "ce:indexed-name": "Swanson R."
                                }
                            ]},
                            "ref-sourcetitle": "Distribution and marketing of drugs in Canada: overview"
                        },
                        "ce:source-text": "Graham JS, Swanson R. Distribution and marketing of drugs in Canada: overview; 2018. Available from: https://ca.practicallaw.thom sonreuters.com/0-618-6695?transitionType=Default&contextData= (sc.Default)&firstPage=true&bhcp=1. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Government of Canada. Health products advertising on physician web sites \u2013 questions and answers; 2011. Available from: https://www.canada. ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/health-products-advertising-physician-questions-answers.html. Accessed April 25, 2020.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/health-products-advertising-physician-questions-answers.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85033550128",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Government of Canada. Accessed April 25, 2020",
                            "ref-sourcetitle": "Health products advertising on physician web sites \u2013 questions and answers"
                        },
                        "ce:source-text": "Government of Canada. Health products advertising on physician web sites \u2013 questions and answers; 2011. Available from: https://www.canada. ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/health-products-advertising-physician-questions-answers.html. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Health Sciences Authority. Advertisements and promotions of therapeutic products; 2019. Available from: https://www.hsa.gov.sg/ther apeutic-products/advertisements. Accessed April 25, 2020.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.hsa.gov.sg/therapeutic-products/advertisements",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097905638",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Health Sciences Authority. Accessed April 25, 2020",
                            "ref-sourcetitle": "Advertisements and promotions of therapeutic products"
                        },
                        "ce:source-text": "Health Sciences Authority. Advertisements and promotions of therapeutic products; 2019. Available from: https://www.hsa.gov.sg/ther apeutic-products/advertisements. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The international comparative legal guide to: pharmaceutical advertising; 2016. Available from: https://www.jurists.co.jp/sites/default/files/tractate_pdf/en/PA16_Japan.pdf. Accessed April 25, 2020.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.jurists.co.jp/sites/default/files/tractate_pdf/en/PA16_Japan.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097899719",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 25, 2020",
                            "ref-sourcetitle": "The international comparative legal guide to: pharmaceutical advertising"
                        },
                        "ce:source-text": "The international comparative legal guide to: pharmaceutical advertising; 2016. Available from: https://www.jurists.co.jp/sites/default/files/tractate_pdf/en/PA16_Japan.pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thai Food and Drug Administration. Things to know for drug advertisements; 2020. Available from: http://www.fda.moph.go.th/sites/drug/SitePages/advertisement03.aspx. Accessed April 25, 2020.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.moph.go.th/sites/drug/SitePages/advertisement03.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097871262",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thai Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "Things to know for drug advertisements"
                        },
                        "ce:source-text": "Thai Food and Drug Administration. Things to know for drug advertisements; 2020. Available from: http://www.fda.moph.go.th/sites/drug/SitePages/advertisement03.aspx. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Baker M. Promoting medical products globally; 2018. Available from: https://www.bakermckenzie.com/-/media/files/insight/publica tions/2018/03/healthcare/ap/promoting-medical-products-globally_malaysia.pdf?la=en. Accessed April 25, 2020.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.bakermckenzie.com/-/media/files/insight/publications/2018/03/healthcare/ap/promoting-medical-products-globally_malaysia.pdf?la=en",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097896108",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 25, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "ce:surname": "Baker",
                                "ce:indexed-name": "Baker M."
                            }]},
                            "ref-sourcetitle": "Promoting medical products globally"
                        },
                        "ce:source-text": "Baker M. Promoting medical products globally; 2018. Available from: https://www.bakermckenzie.com/-/media/files/insight/publica tions/2018/03/healthcare/ap/promoting-medical-products-globally_malaysia.pdf?la=en. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The ministry of health in collaboration with the World Health Organization. Philippines pharmaceutical country profile; 2011. Available from: https://www.who.int/medicines/areas/coordination/Philippines_PSCPBNarrativeQuestionnaireEndorsement_13062012. pdf?ua=1. Accessed April 25, 2020.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/medicines/areas/coordination/Philippines_PSCPBNarrativeQuestionnaireEndorsement_13062012.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85079982221",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The ministry of health in collaboration with the World Health Organization. Accessed April 25, 2020",
                            "ref-sourcetitle": "Philippines pharmaceutical country profile"
                        },
                        "ce:source-text": "The ministry of health in collaboration with the World Health Organization. Philippines pharmaceutical country profile; 2011. Available from: https://www.who.int/medicines/areas/coordination/Philippines_PSCPBNarrativeQuestionnaireEndorsement_13062012. pdf?ua=1. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The food, drug, and cosmetic act, code of federal regulations. 2019.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097863998",
                                "@idtype": "SGR"
                            }},
                            "ref-sourcetitle": "The food, drug, and cosmetic act, code of federal regulations"
                        },
                        "ce:source-text": "The food, drug, and cosmetic act, code of federal regulations. 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Medicines act 1968. 2020.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1968"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0002324467",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "2020",
                            "ref-sourcetitle": "Medicines act"
                        },
                        "ce:source-text": "Medicines act 1968. 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Japan Pharmaceutical Manufacturers Association. Pharmaceutical administration and regulations in Japan; 2019. Available from: http://www.jpma.or.jp/english/parj/pdf/2019.pdf. Accessed January 12, 2020.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.jpma.or.jp/english/parj/pdf/2019.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097870643",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Japan Pharmaceutical Manufacturers Association. Accessed January 12, 2020",
                            "ref-sourcetitle": "Pharmaceutical administration and regulations in Japan"
                        },
                        "ce:source-text": "Japan Pharmaceutical Manufacturers Association. Pharmaceutical administration and regulations in Japan; 2019. Available from: http://www.jpma.or.jp/english/parj/pdf/2019.pdf. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Health Products Act. 2016. Available from: https://sso.agc.gov.sg/SL/HPA2007-S329-2016. Accessed Jan 12, 2020.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://sso.agc.gov.sg/SL/HPA2007-S329-2016",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097871441",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Health Products Act. Accessed Jan 12, 2020"
                        },
                        "ce:source-text": "Health Products Act. 2016. Available from: https://sso.agc.gov.sg/SL/HPA2007-S329-2016. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "National Association of Pharmacy Regulatory Authorities. Drug scheduling in Canada \u2013 general overview; 2019. Available from: https://napra.ca/drug-scheduling-canada-general-overview. Accessed December 10, 2019.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://napra.ca/drug-scheduling-canada-general-overview",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097869745",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "National Association of Pharmacy Regulatory Authorities. Accessed December 10, 2019",
                            "ref-sourcetitle": "Drug scheduling in Canada \u2013 general overview"
                        },
                        "ce:source-text": "National Association of Pharmacy Regulatory Authorities. Drug scheduling in Canada \u2013 general overview; 2019. Available from: https://napra.ca/drug-scheduling-canada-general-overview. Accessed December 10, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "U.S. Food and Drug Administration. How to buy medicines safely from an online pharmacy; 2018. Available from: https://www.fda. gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy. Accessed April 25, 2020.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097892651",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "How to buy medicines safely from an online pharmacy"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. How to buy medicines safely from an online pharmacy; 2018. Available from: https://www.fda. gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "GOV.UK. Register for the distance selling logo; 2017. Available from: https://www.gov.uk/guidance/register-for-the-distance-selling-logo. Accessed April 25, 2020.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.gov.uk/guidance/register-for-the-distance-selling-logo",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097886634",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "GOV.UK. Accessed April 25, 2020",
                            "ref-sourcetitle": "Register for the distance selling logo"
                        },
                        "ce:source-text": "GOV.UK. Register for the distance selling logo; 2017. Available from: https://www.gov.uk/guidance/register-for-the-distance-selling-logo. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ministry of Health Malaysia. Tips on how to buy medicines online; 2020. Available from: https://www.pharmacy.gov.my/v2/en/content/tips-how-buy-medicines-online.html. Accessed April 25, 2020.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pharmacy.gov.my/v2/en/content/tips-how-buy-medicines-online.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097905764",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Ministry of Health Malaysia. Accessed April 25, 2020",
                            "ref-sourcetitle": "Tips on how to buy medicines online"
                        },
                        "ce:source-text": "Ministry of Health Malaysia. Tips on how to buy medicines online; 2020. Available from: https://www.pharmacy.gov.my/v2/en/content/tips-how-buy-medicines-online.html. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Government of Canada. Choosing a safe online pharmacy; 2020. Available from: https://www.canada.ca/en/health-canada/topics/buy ing-using-drug-health-products-safely/safe-use-online-pharmacies. html. Accessed April 25, 2020.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.canada.ca/en/health-canada/topics/buying-using-drug-health-products-safely/safe-use-online-pharmacies.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097911599",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Government of Canada. Accessed April 25, 2020",
                            "ref-sourcetitle": "Choosing a safe online pharmacy"
                        },
                        "ce:source-text": "Government of Canada. Choosing a safe online pharmacy; 2020. Available from: https://www.canada.ca/en/health-canada/topics/buy ing-using-drug-health-products-safely/safe-use-online-pharmacies. html. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Faculty of Medicine Ramathibodi Hospital. Online drug sale; 2018. Available from: https://med.mahidol.ac.th/ramapharmacy/th/knowl edge/general/05192016-1800-th. Accessed February 20, 2020.",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://med.mahidol.ac.th/ramapharmacy/th/knowledge/general/05192016-1800-th",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097881568",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Faculty of Medicine Ramathibodi Hospital. Accessed February 20, 2020",
                            "ref-sourcetitle": "Online drug sale"
                        },
                        "ce:source-text": "Faculty of Medicine Ramathibodi Hospital. Online drug sale; 2018. Available from: https://med.mahidol.ac.th/ramapharmacy/th/knowl edge/general/05192016-1800-th. Accessed February 20, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Health Sciences Authority. Explanation note for application of a pharmacy licence; 2016. Available from: https://www.hsa.gov.sg/docs/default-source/hprg-ald/phl_explanation-noteb201f748dd3a4a8ca9bd36f432a3fded.pdf. Accessed April 25, 2020.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.hsa.gov.sg/docs/default-source/hprg-ald/phl_explanation-noteb201f748dd3a4a8ca9bd36f432a3fded.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097910088",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Health Sciences Authority. Accessed April 25, 2020",
                            "ref-sourcetitle": "Explanation note for application of a pharmacy licence"
                        },
                        "ce:source-text": "Health Sciences Authority. Explanation note for application of a pharmacy licence; 2016. Available from: https://www.hsa.gov.sg/docs/default-source/hprg-ald/phl_explanation-noteb201f748dd3a4a8ca9bd36f432a3fded.pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Consumer Healthcare Product Association. FAQs about drug distribution in the United States; 2019. Available from: https://www.chpa. org/FAQDrugDistribution.aspx. Accessed October 23, 2019.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.chpa.org/FAQDrugDistribution.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097891655",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Consumer Healthcare Product Association. Accessed October 23, 2019",
                            "ref-sourcetitle": "FAQs about drug distribution in the United States"
                        },
                        "ce:source-text": "Consumer Healthcare Product Association. FAQs about drug distribution in the United States; 2019. Available from: https://www.chpa. org/FAQDrugDistribution.aspx. Accessed October 23, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "U.S. Food and Drug Administration. Legal requirements for the sale and purchase of drug products containing pseudoephedrine, ephe-drine, and phenylpropanolamine; 2017. Available from: https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and. Accessed January 12, 2020.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85096522867",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Food and Drug Administration. Accessed January 12, 2020",
                            "ref-sourcetitle": "Legal requirements for the sale and purchase of drug products containing pseudoephedrine, ephe-drine, and phenylpropanolamine"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. Legal requirements for the sale and purchase of drug products containing pseudoephedrine, ephe-drine, and phenylpropanolamine; 2017. Available from: https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "National Association of Pharmacy Regulatory Authorities. Implementation of the national drug schedules; 2019. Available from: https://napra.ca/implementation-national-drug-schedules. Accessed January 12, 2020.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://napra.ca/implementation-national-drug-schedules",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097885049",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "National Association of Pharmacy Regulatory Authorities. Accessed January 12, 2020",
                            "ref-sourcetitle": "Implementation of the national drug schedules"
                        },
                        "ce:source-text": "National Association of Pharmacy Regulatory Authorities. Implementation of the national drug schedules; 2019. Available from: https://napra.ca/implementation-national-drug-schedules. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Comprehensive Dangerous Drugs Act. 2002. Available from: https://www.ddb.gov.ph/images/Board_Regulation/2014/BD.REG1.14.pdf. Accessed Jan 12, 2020.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ddb.gov.ph/images/Board_Regulation/2014/BD.REG1.14.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061765463",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-sourcetitle": "Comprehensive Dangerous Drugs Act"
                        },
                        "ce:source-text": "Comprehensive Dangerous Drugs Act. 2002. Available from: https://www.ddb.gov.ph/images/Board_Regulation/2014/BD.REG1.14.pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gauld N, Bryant L, Emmerton L, Kelly F, Kurosawa N, Buetow S. Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries. J Health Serv Res Policy. 2015;20(4):231\u2013239. doi:10.1177/1355819615593302",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1355819615593302",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84954546257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "231",
                                    "@last": "239"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Gauld",
                                    "ce:indexed-name": "Gauld N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Bryant",
                                    "ce:indexed-name": "Bryant L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Emmerton",
                                    "ce:indexed-name": "Emmerton L"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Kelly",
                                    "ce:indexed-name": "Kelly F"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Kurosawa",
                                    "ce:indexed-name": "Kurosawa N"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Buetow",
                                    "ce:indexed-name": "Buetow S."
                                }
                            ]},
                            "ref-sourcetitle": "J Health Serv Res Policy"
                        },
                        "ce:source-text": "Gauld N, Bryant L, Emmerton L, Kelly F, Kurosawa N, Buetow S. Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries. J Health Serv Res Policy. 2015;20(4):231\u2013239. doi:10.1177/1355819615593302"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hennebry S. When a 20 year patent term just isn\u2019t enough: market and data exclusivity; 2018. Available from: https://fpapatents.com/resource?id=483. Accessed April 25, 2020.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://fpapatents.com/resource?id=483",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097879638",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 25, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Hennebry",
                                "ce:indexed-name": "Hennebry S."
                            }]},
                            "ref-sourcetitle": "When a 20 year patent term just isn\u2019t enough: market and data exclusivity"
                        },
                        "ce:source-text": "Hennebry S. When a 20 year patent term just isn\u2019t enough: market and data exclusivity; 2018. Available from: https://fpapatents.com/resource?id=483. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Medicines and Healthcare products Regulatory Agency. How to change the legal classification of a medicine in the UK; 2006. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/277307/Legal_classifica tion_changes.pdf. Accessed April 25, 2020.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/277307/Legal_classification_changes.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097892674",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Medicines and Healthcare products Regulatory Agency. Accessed April 25, 2020",
                            "ref-sourcetitle": "How to change the legal classification of a medicine in the UK"
                        },
                        "ce:source-text": "Medicines and Healthcare products Regulatory Agency. How to change the legal classification of a medicine in the UK; 2006. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/277307/Legal_classifica tion_changes.pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Agency for Care Effectiveness. Drug evaluation methods and process guide; 2018. Available from: http://www.ace-hta.gov.sg/public-data/our-process-and-methods/ACE%20methods%20and%20process% 20guide%20for%20drug%20evaluation%20(5%20Feb%202018).pdf. Accessed April 25, 2020.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.ace-hta.gov.sg/public-data/our-process-and-methods/ACE%20methods%20and%20process%20guide%20for%20drug%20evaluation%20(5%20Feb%202018).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068640682",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Agency for Care Effectiveness. Accessed April 25, 2020",
                            "ref-sourcetitle": "Drug evaluation methods and process guide"
                        },
                        "ce:source-text": "Agency for Care Effectiveness. Drug evaluation methods and process guide; 2018. Available from: http://www.ace-hta.gov.sg/public-data/our-process-and-methods/ACE%20methods%20and%20process% 20guide%20for%20drug%20evaluation%20(5%20Feb%202018).pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gauld NJ. How and Why Do Developed Countries Vary in Reclassifying Medicines from Prescription to Non-Prescription? University of Auckland; 2013.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85057767625",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "University of Auckland",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "NJ.",
                                "@_fa": "true",
                                "ce:surname": "Gauld",
                                "ce:indexed-name": "Gauld NJ."
                            }]},
                            "ref-sourcetitle": "How and Why Do Developed Countries Vary in Reclassifying Medicines from Prescription to Non-Prescription?"
                        },
                        "ce:source-text": "Gauld NJ. How and Why Do Developed Countries Vary in Reclassifying Medicines from Prescription to Non-Prescription? University of Auckland; 2013."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Camargo. Rx-to-OTC switch: expanding to the US over-the-counter market; 2017. Available from: https://camargopharma.com/resources/blog/rx-to-otc-switch-expanding-to-the-us-over-the-counter-market. Accessed April 25, 2020.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://camargopharma.com/resources/blog/rx-to-otc-switch-expanding-to-the-us-over-the-counter-market",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097862362",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Camargo. Accessed April 25, 2020",
                            "ref-sourcetitle": "Rx-to-OTC switch: expanding to the US over-the-counter market"
                        },
                        "ce:source-text": "Camargo. Rx-to-OTC switch: expanding to the US over-the-counter market; 2017. Available from: https://camargopharma.com/resources/blog/rx-to-otc-switch-expanding-to-the-us-over-the-counter-market. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mithun Raja. B, Raghavendra Rao. K. Regulatory and clinical requirements for prescription to OTC switches in USA and India; 2013. Available from: https://www.complianceonline.com/articlefiles/Regulatory_Requirements_Prescription_to_OTC_Switches_USA_ India.pdf. Accessed Jan 12, 2020.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.complianceonline.com/articlefiles/Regulatory_Requirements_Prescription_to_OTC_Switches_USA_India.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097902780",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Raja. B",
                                    "@_fa": "true",
                                    "ce:surname": "Mithun",
                                    "ce:indexed-name": "Mithun Raja. B"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Rao. K.",
                                    "@_fa": "true",
                                    "ce:surname": "Raghavendra",
                                    "ce:indexed-name": "Raghavendra Rao. K."
                                }
                            ]},
                            "ref-sourcetitle": "Regulatory and clinical requirements for prescription to OTC switches in USA and India"
                        },
                        "ce:source-text": "Mithun Raja. B, Raghavendra Rao. K. Regulatory and clinical requirements for prescription to OTC switches in USA and India; 2013. Available from: https://www.complianceonline.com/articlefiles/Regulatory_Requirements_Prescription_to_OTC_Switches_USA_ India.pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "U.S. Food and Drug Administration. Bringing an over-the-counter (OTC) drugs to market; 2020. Available from: https://www.access data.fda.gov/scripts/cder/training/OTC/topic2/topic2/da_01_02_ 0080.htm. Accessed April 25, 2020.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/scripts/cder/training/OTC/topic2/topic2/da_01_02_0080.htm",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097900349",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "Bringing an over-the-counter (OTC) drugs to market"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. Bringing an over-the-counter (OTC) drugs to market; 2020. Available from: https://www.access data.fda.gov/scripts/cder/training/OTC/topic2/topic2/da_01_02_ 0080.htm. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Health Sciences Authority. Therapeutic products guidance; 2019. Available from: https://www.hsa.gov.sg/docs/default-source/hprg/thera peutic-products/guidance-documents/guidance-on-therapeutic-product-registration-in-singapore_jan2019.pdf. Accessed April 25, 2020.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.hsa.gov.sg/docs/default-source/hprg/therapeutic-products/guidance-documents/guidance-on-therapeutic-product-registration-in-singapore_jan2019.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097879764",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Health Sciences Authority. Accessed April 25, 2020",
                            "ref-sourcetitle": "Therapeutic products guidance"
                        },
                        "ce:source-text": "Health Sciences Authority. Therapeutic products guidance; 2019. Available from: https://www.hsa.gov.sg/docs/default-source/hprg/thera peutic-products/guidance-documents/guidance-on-therapeutic-product-registration-in-singapore_jan2019.pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tago S, Ueda A, Kudo R, Guesdon L. Distribution and marketing of drugs in Japan: overview; 2019. Available from: https://uk.practical law.thomsonreuters.com/5-618-3562?transitionType= Default&contextData=(sc.Default)&firstPage=true&comp= pluk&bhcp=1. Accessed April 25, 2020.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://uk.practicallaw.thomsonreuters.com/5-618-3562?transitionType=Default&contextData=(sc.Default)&firstPage=true&comp=pluk&bhcp=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097902177",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 25, 2020",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Tago",
                                    "ce:indexed-name": "Tago S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Ueda",
                                    "ce:indexed-name": "Ueda A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Kudo",
                                    "ce:indexed-name": "Kudo R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Guesdon",
                                    "ce:indexed-name": "Guesdon L."
                                }
                            ]},
                            "ref-sourcetitle": "Distribution and marketing of drugs in Japan: overview"
                        },
                        "ce:source-text": "Tago S, Ueda A, Kudo R, Guesdon L. Distribution and marketing of drugs in Japan: overview; 2019. Available from: https://uk.practical law.thomsonreuters.com/5-618-3562?transitionType= Default&contextData=(sc.Default)&firstPage=true&comp= pluk&bhcp=1. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "National Association of Pharmacy Regulatory Authorities. National drug scheduling factors; 2017. Available from: https://napra.ca/sites/default/files/documents/NDSAC_Scheduling_Factors_website_ September2017.pdf. Accessed January 12, 2020.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://napra.ca/sites/default/files/documents/NDSAC_Scheduling_Factors_website_September2017.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097897922",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "National Association of Pharmacy Regulatory Authorities. Accessed January 12, 2020",
                            "ref-sourcetitle": "National drug scheduling factors"
                        },
                        "ce:source-text": "National Association of Pharmacy Regulatory Authorities. National drug scheduling factors; 2017. Available from: https://napra.ca/sites/default/files/documents/NDSAC_Scheduling_Factors_website_ September2017.pdf. Accessed January 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Katsura H. The approval standards for OTC drugs in Japan; 2015. Available from: http://www.tsmia.or.th/RTD2015/2-Japan%202nd% 20self-CARER%20(PMDA%20Ehidemi%20Katsura).pdf. Accessed January 17, 2020.",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.tsmia.or.th/RTD2015/2-Japan%202nd%20self-CARER%20(PMDA%20Ehidemi%20Katsura).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097903933",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed January 17, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "ce:surname": "Katsura",
                                "ce:indexed-name": "Katsura H."
                            }]},
                            "ref-sourcetitle": "The approval standards for OTC drugs in Japan"
                        },
                        "ce:source-text": "Katsura H. The approval standards for OTC drugs in Japan; 2015. Available from: http://www.tsmia.or.th/RTD2015/2-Japan%202nd% 20self-CARER%20(PMDA%20Ehidemi%20Katsura).pdf. Accessed January 17, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bakah SA. Regulation of OTC medicines in Malaysia; 2017. Available from: https://www.tga.gov.au/sites/default/files/interna tional-over-counter-otc-medicines-regulators-forum-2017-malaysia. pdf. Accessed November 13, 2020.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.tga.gov.au/sites/default/files/international-over-counter-otc-medicines-regulators-forum-2017-malaysia.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097868851",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed November 13, 2020",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "SA.",
                                "@_fa": "true",
                                "ce:surname": "Bakah",
                                "ce:indexed-name": "Bakah SA."
                            }]},
                            "ref-sourcetitle": "Regulation of OTC medicines in Malaysia"
                        },
                        "ce:source-text": "Bakah SA. Regulation of OTC medicines in Malaysia; 2017. Available from: https://www.tga.gov.au/sites/default/files/interna tional-over-counter-otc-medicines-regulators-forum-2017-malaysia. pdf. Accessed November 13, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Official Portal of Pharmaceutical Services Programme, Ministry of Health Malaysia. Application for poisons classification guideline under the poisons act 1952; 2013. Available from: https://www.phar macy.gov.my/v2/sites/default/files/document-upload/garispanduan. pdf. Accessed Jan 12, 2020.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/garispanduan.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097884716",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Official Portal of Pharmaceutical Services Programme, Ministry of Health Malaysia. Accessed Jan 12, 2020",
                            "ref-sourcetitle": "Application for poisons classification guideline under the poisons act 1952"
                        },
                        "ce:source-text": "Official Portal of Pharmaceutical Services Programme, Ministry of Health Malaysia. Application for poisons classification guideline under the poisons act 1952; 2013. Available from: https://www.phar macy.gov.my/v2/sites/default/files/document-upload/garispanduan. pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Policies and guidelines on over-the-counter (OTC) drug products; 2000. Available from: https://ww2.fda.gov.ph/attachments/article/16557/ao%2023c%202000.pdf. Accessed Jan 12, 2020.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ww2.fda.gov.ph/attachments/article/16557/ao%2023c%202000.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097864618",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed Jan 12, 2020",
                            "ref-sourcetitle": "Policies and guidelines on over-the-counter (OTC) drug products"
                        },
                        "ce:source-text": "Policies and guidelines on over-the-counter (OTC) drug products; 2000. Available from: https://ww2.fda.gov.ph/attachments/article/16557/ao%2023c%202000.pdf. Accessed Jan 12, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Republic of the Philippines DoH, Food and Drug Administration. Application process and requirements for post-approval changes of pharmaceutical products; 2014. Available from: https://ww2.fda.gov. ph/attachments/article/148395/FC2014-008%20-%20Application% 20Process%20and%20Requirments%20for%20Post-Approval% 20Changes%20of%20Pharmaceutical%20Products.pdf. Accessed April 25, 2020.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ww2.fda.gov.ph/attachments/article/148395/FC2014-008%20-%20Application%20Process%20and%20Requirments%20for%20Post-Approval%20Changes%20of%20Pharmaceutical%20Products.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097911965",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Republic of the Philippines DoH, Food and Drug Administration. Accessed April 25, 2020",
                            "ref-sourcetitle": "Application process and requirements for post-approval changes of pharmaceutical products"
                        },
                        "ce:source-text": "Republic of the Philippines DoH, Food and Drug Administration. Application process and requirements for post-approval changes of pharmaceutical products; 2014. Available from: https://ww2.fda.gov. ph/attachments/article/148395/FC2014-008%20-%20Application% 20Process%20and%20Requirments%20for%20Post-Approval% 20Changes%20of%20Pharmaceutical%20Products.pdf. Accessed April 25, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ministry of Public Health. 30th notification of dangerous drugs; 2018. Available from: http://www.fda.moph.go.th/sites/drug/Shared %20Documents/Law03-TheMinistryOfHealth/Dangerousdrugs(30). PDF. Accessed August 2, 2020.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/Dangerousdrugs(30).PDF",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097872164",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Ministry of Public Health. Accessed August 2, 2020",
                            "ref-sourcetitle": "30th notification of dangerous drugs"
                        },
                        "ce:source-text": "Ministry of Public Health. 30th notification of dangerous drugs; 2018. Available from: http://www.fda.moph.go.th/sites/drug/Shared %20Documents/Law03-TheMinistryOfHealth/Dangerousdrugs(30). PDF. Accessed August 2, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ministry of Public Health. 53th notification of specially controlled drugs; 2019. Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/SPC(53).pdf. Accessed August 2, 2020.",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/SPC(53).pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85097885134",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Ministry of Public Health. Accessed August 2, 2020",
                            "ref-sourcetitle": "53th notification of specially controlled drugs"
                        },
                        "ce:source-text": "Ministry of Public Health. 53th notification of specially controlled drugs; 2019. Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/SPC(53).pdf. Accessed August 2, 2020."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "125552434",
            "affilname": "DKSH (Thailand) Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125552434",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "125551936",
            "affilname": "Reckitt Benckiser (Thailand) Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125551936",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "100458316",
            "affilname": "Medical Association of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100458316",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85097869212",
        "dc:description": "Purpose: The drug classification system, as prescription or non-prescription drug category, has been utilized as a regulatory strategy to ensure patient safety. In Thailand, the same system has been used for decades, though the drug classification criteria were updated to accommodate drug re-classification in 2016. These new criteria, however, have not been applied retroactively. Inconsistency in drug classification has been observed leading to concerns regarding the drug classification system. This has prompted the need for a review of the drug classification system in Thailand. This study aims to explore Thailand and other selected countries\u2019 regulatory management regarding the drug classification system, drug classification criteria, and drug classification itself. Methods: The drug classification systems of the United States, the United Kingdom, Japan, Singapore, Malaysia, the Philippines, and Canada were selected to study alongside Thailand\u2019s system. The regulatory review was conducted through each country\u2019s drug regulatory agency website and available published research. Complementary interviews with drug regulatory authorities were conducted when written documentation was unclear and had limited access. Fifty-two common drugs were selected to compare their actual classifications across the different countries. Results: All selected countries classified drugs into two major groups: prescription drugs and non-prescription drugs. The studied countries further sub-classified non-prescription drugs into 1\u20134 categories. Principles of drug classification criteria among countries are similar; they comprised of three themes: disease characteristics, drug safety profile, and other drug char-acteristics. Actual drug classification of antibiotics, dyslipidemia treatments, and hypertension treatments in Thailand are notedly different from other countries. Furthermore, 77.4% of drugs studied in Thailand fall into the behind-the-counter (dangerous) drug category, which varied from antihistamines to antibiotics, dyslipidemia treatments, and vaccines. Conclusion: Thailand\u2019s drug classification criteria are comparable with other nations; however, there is a need to review drug classification statuses as many drugs have been classified into improper drug categories.",
        "prism:coverDate": "2020-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85097869212",
        "dc:creator": {"author": [{
            "ce:given-name": "Doungporn",
            "preferred-name": {
                "ce:given-name": "Doungporn",
                "ce:initials": "D.",
                "ce:surname": "Leelavanich",
                "ce:indexed-name": "Leelavanich D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Leelavanich",
            "@auid": "57220929529",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220929529",
            "ce:indexed-name": "Leelavanich D."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85097869212"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85097869212&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85097869212&origin=inward"
            }
        ],
        "source-id": "19700182697",
        "citedby-count": "11",
        "prism:volume": "13",
        "subtype": "ar",
        "dc:title": "Prescription and non-prescription drug classification systems across countries: Lessons learned for thailand",
        "openaccess": "1",
        "prism:issn": "11791594",
        "publishercopyright": "Â© 2020 Leelavanich et al.",
        "subtypeDescription": "Article",
        "prism:publicationName": "Risk Management and Healthcare Policy",
        "prism:pageRange": "2753-2768",
        "prism:endingPage": "2768",
        "openaccessFlag": "true",
        "prism:doi": "10.2147/RMHP.S281629",
        "prism:startingPage": "2753",
        "dc:identifier": "SCOPUS_ID:85097869212",
        "dc:publisher": "Dove Medical Press Ltd"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Classification criteria"
        },
        {
            "@_fa": "true",
            "$": "Drug category"
        },
        {
            "@_fa": "true",
            "$": "Drug regulatory"
        },
        {
            "@_fa": "true",
            "$": "Non-prescription"
        },
        {
            "@_fa": "true",
            "$": "OTC"
        },
        {
            "@_fa": "true",
            "$": "Prescription"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Doungporn",
            "preferred-name": {
                "ce:given-name": "Doungporn",
                "ce:initials": "D.",
                "ce:surname": "Leelavanich",
                "ce:indexed-name": "Leelavanich D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Leelavanich",
            "@auid": "57220929529",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220929529",
            "ce:indexed-name": "Leelavanich D."
        },
        {
            "ce:given-name": "Noppadon",
            "preferred-name": {
                "ce:given-name": "Noppadon",
                "ce:initials": "N.",
                "ce:surname": "Adjimatera",
                "ce:indexed-name": "Adjimatera N."
            },
            "@seq": "2",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "100458316",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100458316"
                },
                {
                    "@id": "125551936",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125551936"
                }
            ],
            "ce:surname": "Adjimatera",
            "@auid": "9250334900",
            "author-url": "https://api.elsevier.com/content/author/author_id/9250334900",
            "ce:indexed-name": "Adjimatera N."
        },
        {
            "ce:given-name": "Lawanworn",
            "preferred-name": {
                "ce:given-name": "Lawanworn",
                "ce:initials": "L.",
                "ce:surname": "Broese Van Groenou",
                "ce:indexed-name": "Broese Van Groenou L."
            },
            "@seq": "3",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "125552434",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125552434"
            },
            "ce:surname": "Broese Van Groenou",
            "@auid": "57220925799",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220925799",
            "ce:indexed-name": "Broese Van Groenou L."
        },
        {
            "ce:given-name": "Puree",
            "preferred-name": {
                "ce:given-name": "Puree",
                "ce:initials": "P.",
                "ce:surname": "Anantachoti",
                "ce:indexed-name": "Anantachoti P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Anantachoti",
            "@auid": "6506845858",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506845858",
            "ce:indexed-name": "Anantachoti P."
        }
    ]}
}}